[1]
“High Prevalence of Obesity and Related Complications with Limited Utilization of Obesity Medication in Patients with Psoriasis or Psoriatic Arthritis: Real-World Clinical Insights from the US”, J of Skin, vol. 9, no. 6, p. s639, Nov. 2025, doi: 10.25251/2eee8k43.